NCT01801124View on ClinicalTrials.gov

EXPAREL Infiltrated Into the TAP for Postoperative Analgesia in Unilateral Abdominal Hernia Repair

PHASE4CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Hernia
Interventions
DRUG

EXPAREL

single dose 266 mg of undiluted EXPAREL

Trial Locations (1)

11219

Maimonides Medical Center, Brooklyn

Sponsors
All Listed Sponsors
lead

Pacira Pharmaceuticals, Inc

INDUSTRY